Ketoreductases have been used as catalysts for the enantioselective conversion of desired prochiral ketones to the corresponding alcohols, i.e. ketoreductases can reduce ketones to produce chiral alcohols. The scientific research and technical team of Jinran Bio has 10+ years of experience in catalytic enzyme development and 6+ years of experience in the synthesis of pharmaceutical intermediates. Equipped with biocatalytic enzymes and chiral pharmaceutical intermediates and other products required by the market to help your drug development and quality control (quality control).